Mediators of the improvement in heart failure outcomes with empagliflozin in the EMPA-REG OUTCOME trial.
Document Type
Journal Article
Publication Date
10-4-2021
Journal
ESC Heart Failure
DOI
10.1002/ehf2.13615
Recommended Citation
Fitchett, D., Inzucchi, S., Zinman, B., Wanner, C., Schumacher, M., Schmoor, C., Ohneberg, K., Ofstad, A., Salsali, A., George, J., Hantel, S., Bluhmki, E., Lachin, J. M., & Zannad, F. (2021). Mediators of the improvement in heart failure outcomes with empagliflozin in the EMPA-REG OUTCOME trial.. ESC Heart Failure, (). http://dx.doi.org/10.1002/ehf2.13615
Peer Reviewed
1
Open Access
1
Comments
Online ahead of print